Fig. 8
Schematic diagram of the pathways that lead to the differential responses of HCT116 p53-wild-type and p53-null cells toward oxaliplatin
Fig. 8 | Journal of Experimental & Clinical Cancer Research
Schematic diagram of the pathways that lead to the differential responses of HCT116 p53-wild-type and p53-null cells toward oxaliplatin